You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study

 

Online download statistics by month:

Online download statistics by month: March 2021 to April 2022

AbstractFullPdf
Mar 2021386386174
Apr 202110710756
May 2021777736
Jun 202117417437
Jul 2021929220
Aug 202110010017
Sep 2021717125
Oct 2021787844
Nov 202111311343
Dec 202110610735
Jan 2022676944
Feb 202210810844
Mar 2022606230
Apr 2022707742
Total16091621647